3月18日 - ** 生物技术公司 Aditxt Inc ADTX.O 股价上涨 122% 至 9.68 美元
** ADTX收购加拿大药物开发商Appili Therapeutics APLI.TO的 (link),在APLI给予豁免后,收购截止日期延长至3月31日 (link)。
** APLI 的交易已获得法院批准,其股东已投票赞成交易
** 然而,交易仍取决于 ADTX 能否获得足够的融资
** APLI 将在被收购后从多伦多证券交易所退市,预计时间为 2025 年第一季度
**ADTX 股票成交量超过 5190 万股,是其 25 天移动平均值的 73 倍
(为便利非英文母语者,路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.